Cadonilizumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cadonilizumab, covering 2025-06-12 to 2025-06-12. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer [Phase 2]